| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8773682 | Kidney International Reports | 2018 | 40 Pages |
Abstract
Combining FC-XM and solid-phase assays with the evaluation of donor/recipient HLA eplet mismatches, are most accurate tools for immune-risk stratification prior LDKT.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Maria Meneghini, Edoardo Melilli, Jaume Martorell, Ignacio Revuelta, Elisabet Rigol-Monzó, Anna Manonelles, Nuria Montero, David Cucchiari, Fritz Diekmann, Josep M. Cruzado, Salvador Gil-Vernet, Josep M. Grinyó, Oriol Bestard,